The department of pharmacodynamics recently appointed Daohong Zhou, M.D., as a new professor in the University of Florida College of Pharmacy. He also holds the titles of professor of radiation oncology in the UF College of Medicine and associate director for translation and drug development and the Harry E. Innes Endowed Professor of Cancer Research in the UF Health Cancer Center. Zhou received his medical training from Yunyany Medical College of Tongji Medical University in China and graduate training at Henan Medical University in India. His completed postdoctoral training at the Johns Hopkins University School of Medicine. Before joining UF, he was a professor of pharmaceutical sciences and the deputy director of the division of radiation health at the University of Arkansas for Medical Sciences, or UAMS, College of Pharmacy and the associate director for basic research at the Winthrop P. Rockefeller Cancer Institute at UAMS.
Zhou has published more than 100 peer reviewed scientific articles and book chapters. His research has been well supported by grants from various private and government funding agencies, including the National Cancer Institute and National Institute of Allergy and Infectious Disease. Zhou serves on several national and international peer review panels and as a reviewer for various scientific publications. He was a regular member of the Radiation Therapeutics and Biology Study Section at the National Institutes of Health and a co-chair of the Panel Meeting for General Program of the Dept. of Health Sciences (hematology) at the National Natural Science Foundation of China. He is a councilor of the Radiation Research Society and a co-founder of Unity Biotechnology, a biotech that develops senolytic drugs for aging and age-related diseases.